Cipla Rationalizes Sri Lanka Operations

Open To Inorganic Growth Opportunities

Looking to rationalize its Sri Lankan operations, Cipla buys 40% stake held by joint venture partner Citihealth Imports in Cipla Pharma Lanka. Wholly-owned subsidiary Breathe Free Sri Lanka will be its vehicle for growth in the country.

SC1808_Biz-Puzzle_1005619939_1200.jpg
Cipla, Citihealth will now go their own ways • Source: Shutterstock

Cipla Ltd.’s five-year old joint venture with Citihealth Imports (Pvt) Ltd has ended, having served its purpose of allowing the Indian company to entrench itself deeper in a market it has been present in for over 20 years.

In 2014, Cipla set up a marketing and distribution joint venture, Cipla Pharma Lanka (Pvt) Ltd, with Sri Lankan distributor...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip